A detailed history of Susquehanna International Group, LLP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 83,400 shares of WVE stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,400
Previous 78,048 6.86%
Holding current value
$1.14 Million
Previous $389,000 75.58%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$4.38 - $6.48 $341,850 - $505,751
78,048 New
78,048 $389,000
Q4 2023

Feb 14, 2024

SELL
$4.16 - $6.87 $36,029 - $59,501
-8,661 Reduced 28.66%
21,558 $108,000
Q3 2023

Nov 14, 2023

BUY
$3.56 - $5.75 $37,579 - $60,697
10,556 Added 53.68%
30,219 $173,000
Q2 2023

Aug 11, 2023

SELL
$3.51 - $4.69 $2.49 Million - $3.33 Million
-709,925 Reduced 97.3%
19,663 $71,000
Q1 2023

May 16, 2023

BUY
$3.58 - $6.3 $1.47 Million - $2.58 Million
409,453 Added 127.9%
729,588 $3.16 Million
Q4 2022

Feb 14, 2023

BUY
$3.18 - $7.0 $905,215 - $1.99 Million
284,659 Added 802.4%
320,135 $2.24 Million
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $84,078 - $151,837
35,476 New
35,476 $128,000
Q4 2021

Feb 14, 2022

BUY
$3.14 - $5.15 $20,745 - $34,026
6,607 Added 65.66%
16,670 $52,000
Q3 2021

Nov 15, 2021

SELL
$4.89 - $7.12 $248,045 - $361,162
-50,725 Reduced 83.45%
10,063 $49,000
Q2 2021

Aug 11, 2021

SELL
$5.65 - $7.47 $74,873 - $98,992
-13,252 Reduced 17.9%
60,788 $405,000
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $353,357 - $756,473
62,987 Added 569.86%
74,040 $415,000
Q4 2020

Feb 16, 2021

SELL
$6.99 - $9.26 $923,029 - $1.22 Million
-132,050 Reduced 92.28%
11,053 $87,000
Q3 2020

Nov 16, 2020

BUY
$8.49 - $19.54 $53,461 - $123,043
6,297 Added 4.6%
143,103 $1.22 Million
Q2 2020

Aug 14, 2020

BUY
$7.44 - $11.29 $485,921 - $737,372
65,312 Added 91.35%
136,806 $1.42 Million
Q1 2020

May 15, 2020

BUY
$6.94 - $14.22 $29,411 - $60,264
4,238 Added 6.3%
71,494 $670,000
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $350,968 - $1.65 Million
43,926 Added 188.28%
67,256 $539,000
Q3 2019

Nov 14, 2019

BUY
$19.17 - $27.4 $51,893 - $74,171
2,707 Added 13.13%
23,330 $479,000
Q2 2019

Aug 16, 2019

BUY
$22.93 - $42.84 $90,435 - $168,960
3,944 Added 23.65%
20,623 $538,000
Q2 2019

Aug 14, 2019

BUY
$22.93 - $42.84 $382,449 - $714,528
16,679 New
16,679 $435,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.19B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.